Cocarcinogenic effects of islet hormones and N-nitrosomorpholine in hepatocarcinogenesis after intrahepatic transplantation of pancreatic islets in streptozotocin-diabetic rats

Cancer Research

Volumn 65, Issue 15, 2005, Pages 7013-7022

  Dombrowski, Frank ^a   Jost, Christina Maria ^b   Manekeller, Steffen ^c   Evert, Matthias ^a  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

^b ST FRANZISKUS HOSPITAL   (Germany)

^c UNIVERSITY HOSPITAL BONN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN; NITROSOMORPHOLINE; PANCREAS HORMONE; POLYSTYRENE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER MODEL; CARCINOGENICITY; CONTROLLED STUDY; DIABETES MELLITUS; IN VIVO STUDY; LIVER ADENOMA; LIVER CARCINOGENESIS; LIVER CARCINOMA; LIVER CELL; MALE; NONHUMAN; PANCREAS ISLET TRANSPLANTATION; PRECANCER; PRIORITY JOURNAL; RAT; STREPTOZOCIN DIABETES;

ANIMALS; BLOOD GLUCOSE; CARCINOGENS; COCARCINOGENESIS; DIABETES MELLITUS, EXPERIMENTAL; ISLETS OF LANGERHANS TRANSPLANTATION; LIVER NEOPLASMS; MALE; NITROSAMINES; PRECANCEROUS CONDITIONS; RATS; RATS, INBRED LEW;

EID: 23044470044     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-05-0122     Document Type: Article

References (34)

1. Bannasch P. The cytoplasm of hepatocytes during carcinogenesis. Electron- and lightmicroscopical investigations of the nitrosomorpholine-intoxicated rat liver. In: Rentchnick P, editor. Recent results in cancer research (Volume 19). Berlin-Heidelberg: Springer: 1968. p. 1-100.
2. Mayer D, Metzger C, Leonetti P, Beier K, Benner A, Bannasch P. Differential expression of key enzymes of energy metabolism in preneoplastic and neoplastic rat liver lesions induced by N-nitrosomorpholine and dehydroepiandrosterone. Int J Cancer 1998;79:232-40.
3. Ströbel P, Klimek F, Zerban H, Kopp-Schneider A, Bannasch P. Xenomorphic hepatocellular precursors and neoplastic progression of tigroid cell foci induced in rats with low doses of N-nitrosomorpholine. Carcinogenesis 1998;19:2069-80.
4. Weber E, Bannasch P. Dose and time dependence of the cellular phenotype in rat hepatic preneoplasia and neoplasia induced by single oral exposures to N-nitrosomorpholine. Carcinogenesis 1994;15:1219-26.
5. Weber E, Bannasch P. Dose and time dependence of the cellular phenotype in rat hepatic preneoplasia and neoplasia induced in stop experiment by oral exposure to N-nitrosomorpholine. Carcinogenesis 1994;15:1227-34.
6. Weber E, Bannasch P. Dose and time dependence of the cellular phenotype in rat hepatic preneoplasia and neoplasia induced by continuous oral exposure to N-nitrosomorpholin. Carcinogenesis 1994;15:1235-42.
7. Hacker HJ, Moore MA, Mayer D, Bannasch P. Correlative histochemistry of some enzymes of carbohydrate metabolism in preneoplastic and neoplastic lesions in the rat liver. Carcinogenesis 1982;3:1265-72.
8. Mayer D, Klimek F, Bannasch P. Cytochemical and biochemical studies on adenylate cyclase activity in preneoplastic and neoplastic liver tissue and cultured liver cells. Microsc Res Tech 1998;40:463-72.
9. Klimek F, Bannasch P. Biochemical microanalysis of α-glucosidase activity in preneoplastic and neoplastic hepatic lesions induced in rats by N-nitrosomorpholine. Virchows Arch B Cell Pathol Incl Mol Pathol 1989;57: 245-50.
10. Ehemann V, Mayer D, Hacker HJ, Bannasch P. Loss of adenylate cyclase activity in preneoplastic and neoplastic lesions induced in rat liver by N-nitrosomorpholine. Carcinogenesis 1986;7:567-73.
11. Klimek F, Mayer D, Bannasch P. Biochemical microanalysis of glycogen content and glucose-6-phosphate dehydrogenase activity in focal lesions of the rat liver induced by N-nitrosomorpholin. Carcinogenesis 1984;5:265-8.
12. Moore MA, Mayer D, Bannasch P. The dose dependence and sequential appearance of putative preneoplastic populations induced in the rat liver by stop experiments with N-nitrosomorpholine. Carcinogenesis 1982;3:1429-36.
13. Bannasch P, Nehrbass D, Kopp-Schneider A. Significance of hepatic preneoplasia for cancer chemoprevention. In: Miller AB, Bartsch H, Bofetta P, Dragsted L, Vainio H, editors. Biomarkers in cancer chemoprevention, no. 154, IARC Sci Publ. Lyon: IARC Press; 2001. p. 223-40.
14. Bannasch P, Klimek F, Mayer D. Early bioenergetic changes in hepatocarcinogenesis: preneoplastic phenotypes mimic responses to insulin and thyroid hormone. J Bioenerg Biomembr 1997;29:303-13.
15. Dombrowski F, Lehringer-Polzin M, Pfeifer U. Hyperproliferative liver acini after intraportal islet transplantation in streptozotocin-induced diabetic rats. Lab Invest 1994;71:688-99.
16. Dombrowski F, Filsinger E, Bannasch P, Pfeifer U. Altered liver acini induced in diabetic rats by portal vein islet isografts resemble preneoplastic hepatic foci in their enzymic pattern. Am J Pathol 1996;148:1249-56.
17. Dombrowski F, Bannasch P, Pfeifer U. Hepatocellular neoplasms induced by low-number pancreatic islet transplants in streptozotocin diabetic rats. Am J Pathol 1997;150:1071-87.
18. Scharf JG, Ramadori G, Dombrowski F. Analysis of the IGF axis in preneoplastic hepatic foci and hepatocellular neoplasms developing after low-number pancreatic islet transplantation into the livers of streptozotocin diabetic rats. Lab Invest 2000;80: 1399-411.
19. Evert M, Schneider-Stock R, Dombrowski F. Over-expression of fatty acid synthase in chemically and hormonally induced hepatocarcinogenesis of the rat. Lab Invest 2005;85:99-108.
20. Kuhajda F. Fatty-acid synthase and human cancer: new perspectives on its role in tumor biology. Nutrition 2000;16:202-8.
21. Evert M, Sun JP, Pichler S, Slavova N, Schneider-Stock R, Dombrowski F. Insulin receptor, insulin receptor substrate-1, Raf-1. and Mek-1 during hormonal hepatocarcinogenesis by intrahepatic pancreatic islet transplantation in diabetic rats. Cancer Res 2004;64:8093-100.
22. Weibel ER. Stereological principles for morphometry in electron microscopic cytology. Int Rev Cytol 1969;26:235-302.
23. Evert M, Schneider-Stock R, Dombrowski F. Apolipoprotein A-IV mRNA overexpression in early preneoplastic hepatic foci induced by low-number pancreatic islet transplants in streptozotocin-diabetic rats. Pathol Res Pract 2003;199:373-9.
24. Dombrowski F, Klingmüller D, Pfeifer U. Insulinomas derived from hyperplastic intra-hepatic islet transplants. Am J Pathol 1998;152:1025-38.
25. Nehrbass D, Klimek F, Bannasch P. Overexpression of insulin receptor substrate-1 emerges early in hepatocarcinogenesis and elicits preneoplastic hepatic glycogenosis. Am J Pathol 1998;152:341-5.
26. Nehrbass D, Klimek F, Bannasch P, Mayer D. Insulin receptor substrate-1 is over-expressed in glycogenotic but not in amphophilic preneoplastic hepatic foci induced in rats by N-nitrosomorpholine and dehydroepiandrosterone. Cancer Lett 1999;140:75-9.
27. Bannasch P, Haertel T, Su Q. Significance of hepatic preneoplasia in risk identification and early detection of neoplasia. Toxicol Pathol 2003;31:134-9.
28. Kazumi T, Yoshino G, Fujii S, Baba S. Tumorigenic action of streptozotocin on the pancreas and kidney in male Wistar rats. Cancer Res 1978;38:2144-7.
29. Rother KI, Harlan DM. Challenges facing islet transplantation for the treatment of type 1 diabetes mellitus. J Clin Invest 2004;114:877-83.
30. Ricordi C, Strom TB. Clinical islet transplantation: advances and immunological challenges. Nat Rev Immunol 2004;4:259-68.
31. Shapiro AM, Lakey JR, Ryan EA, et al. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med 2000;343:230-8.
32. Street CN, Lakey JR, Shapiro AM, et al. Islet graft assessment in the Edmonton protocol: implications for predicting long-term clinical outcome. Diabetes 2004;53:3107-14.
33. Hirshberg B, Mog S, Patterson N, Leconte J, Harlan DM. Histopathological study of intrahepatic islets transplanted in the nonhuman primate model using Edmonton protocol immunosuppression. J Clin Endocrinol Metab 2002;87:5424-9.
34. Su Q, Bannasch P. Relevance of hepatic preneoplasia for human hepatocarcinogenesis. Toxicol Pathol 2003;31:126-33.